Phase Behavior of Drug–Lipid–Surfactant Ternary Systems toward Understanding the Annealing-Induced Change
- 27 December 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 19 (2) , 532-546
Abstract
The present study systematically investigates the effect of annealing conditions and the Kolliphor P 407 content on the physicochemical and structural properties of Compritol (glyceryl behenate) and ternary systems prepared via melt cooling (Kolliphor P 407, Compritol, and a hydrophilic API) representing solid–lipid formulations. The physical properties of Compritol and the ternary systems with varying ratios of Compritol and Kolliphor P 407 were characterized using differential scanning calorimetry (DSC), small- and wide-angle X-ray scattering (SWAXS) and infrared (IR) spectroscopy, and hot-stage microscopy (HSM), before and after annealing. The change in the chemical profiles of different Compritol components as a function of annealing was evaluated using 1H NMR spectroscopy. While no change in the polymorphic form of API and Kolliphor P 407 occurred during annealing, a systematic conversion of the α- to β-form was observed in the case of Compritol. Furthermore, the polymorphic transformation of Compritol was found to be dependent on the Kolliphor P 407 content. As per the Flory–Huggins mixing theory, higher miscibility was observed in the case of monobehenin–Kolliphor P 407, monobehenin–dibehenin, and dibehenin–tribehenin binary mixtures. The miscibility of Kolliphor P 407 with monobehenin and 1,2-dibehenin was confirmed by 1H NMR analysis. The observed higher miscibility of Kolliphor P 407 with monobehenin and 1,2-dibehenin is proposed as the trigger for the physical separation from the 1,3-diglyceride and triglycerides during melt solidification of the formulations. The phase separation is postulated as the mechanism underlying the formation of a stable β-polymorphic form (a native form of 1,3-diglyceride) of Compritol upon annealing. This finding is expected to have an important implication for developing stable solid–lipid–surfactant-based drug formulations.Keywords
Funding Information
- ??sterreichische Forschungsf??rderungsgesellschaft
This publication has 21 references indexed in Scilit:
- Role of Lipid Blooming and Crystallite Size in the Performance of Highly Soluble Drug-Loaded MicrocapsulesJournal of Pharmaceutical Sciences, 2015
- Polymorphism of glyceryl behenates: From the individual compounds to the pharmaceutical excipientChemistry and Physics of Lipids, 2014
- Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticalsExpert Opinion on Drug Delivery, 2014
- Prediction of Drug–Polymer Miscibility through the use of Solubility Parameter based Flory–Huggins Interaction Parameter and the Experimental Validation: PEG as Model PolymerJournal of Pharmaceutical Sciences, 2013
- Controlled release of a highly hydrophilic API from lipid microspheres obtained by prilling: Analysis of drug and water diffusion processes with X-ray-based methodsJournal of Controlled Release, 2012
- Triacylglycerols profiling in plant oils important in food industry, dietetics and cosmetics using high-performance liquid chromatography–atmospheric pressure chemical ionization mass spectrometryJournal of Chromatography A, 2008
- Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopyInternational Journal of Pharmaceutics, 2007
- Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLCJournal of Microencapsulation, 2006
- Physical and thermal characterisation of Precirol® and Compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pelletsInternational Journal of Pharmaceutics, 2003
- Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInternational Journal of Pharmaceutics, 1998